You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 12 No. 5, May 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Copper Balance Studies In Wilson's Disease

Observations on the Effect of Penicillamine, Carbacrylamine Resins, and Potassium Sulfide

NORMAN P. GOLDSTEIN, MD; RAYMOND V. RANDALL, MD; JOHN B. GROSS, MD; WARREN F. McGUCKIN, PhD

Arch Neurol. 1965;12(5):456-462.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A LTHOUGH it is generally recognized that Wilson's disease (hepatolenticular degeneration) is a genetic disorder involving a disturbance of the metabolism of copper, there are few reports related to studies of copper balance.1-3 Available data indicate that patients who have this disorder absorb greater than normal amounts of copper from the gastrointestinal tract4 and excrete less than normal amounts in the feces.5 However, the mechanisms of intestinal absorption and fecal excretion of copper remain obscure, both in normal individuals and in patients with this illness.

The treatment of Wilson's disease with penicillamine is known to increase the urinary excretion of copper.6,7 Likewise, it has been stated that the oral use of either ion-exchange resins8,9 or potassium sulfide10,11 at mealtime increases the fecal content of copper. In view of the derangement of copper metabolism in this illness, treatment should be aimed at achieving a negative . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER. MINN

From the Mayo Clinic and Mayo Foundation. Section of Neurology (Dr. Goldstein); Section of Medicine (Drs. Randall and Gross); Section of Biochemistry (Dr. McGuckin).


Footnotes

Submitted for publication April 15, 1964; accepted Jan 11, 1965.

Read by title at the meeting of the American Neurological Association, Atlantic City, NJ, June 10-12, 1963.

Reprint requests to Mayo Clinic, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.